Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (2)
  • Autophagy
    (2)
  • DNA Alkylator/Crosslinker
    (2)
  • DNA/RNA Synthesis
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (1)
Filter
Search Result
Results for "

nsc-362856

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Isotope Products
    1
    TargetMol | Isotope_Products
Temozolomide
TZM, TMZ, NSC 362856, CCRG 81045
T117885622-93-1
Temozolomide (TMZ) is a DNA alkylating agent with blood-brain barrier permeability and oral activity. Temozolomide has antitumor activity and antiangiogenic activity, and also induces apoptosis and autophagy. Temozolomide is stable under acidic conditions and hydrolyzes under neutral or slightly alkaline conditions.
  • $42
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Temozolomide-d3
TMID-1105208107-14-6
Temozolomide-d3 is the deuterated form of Temozolomide. Temozolomide (NSC 362856) is an orally active DNA alkylating agent capable of crossing the blood-brain barrier. It also acts as an autophagy inducer and an apoptosis agent. This compound is effective against tumor cells characterized by low levels of O6-alkylguanine-DNA alkyltransferase (OGAT) and dysfunctional mismatch repair systems. Temozolomide exhibits anti-tumor and anti-angiogenic effects.
  • Inquiry Price
Inquiry
Size
QTY